MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-21-2026
Medigus Ltd. Retained Earnings 2011-2026 | MDGS
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Quarterly Retained Earnings Medigus Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -74.2 M | - | -71.9 M | - | -81 M | - | -79.2 M | - | -76.7 M | - | -64.3 M | - | -62.5 M | - | -58.1 M | - | -55.9 M | - | - | - | -53.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -53.3 M | -81 M | -67.7 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.12 | 0.12 % | $ 872 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.6 | -0.44 % | $ 5.45 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 62.34 | -0.76 % | $ 92.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.24 | 1.75 % | $ 1.65 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.37 | - | $ 265 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 34.21 | -1.67 % | $ 1.06 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.63 | 7.41 % | $ 39.2 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.48 | 2.66 % | $ 130 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.03 | -0.02 % | $ 47.4 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.59 | - | $ 122 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 32.72 | -4.99 % | $ 1.51 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.96 | 5.38 % | $ 1.19 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.3 | -2.41 % | $ 716 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 170.69 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.41 | 3.22 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 96.2 | -0.04 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 84.91 | -2.23 % | $ 2.95 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.94 | -0.75 % | $ 374 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
-178 M | $ 5.87 | -3.22 % | $ 70.2 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.38 | 3.76 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.9 | -0.64 % | $ 576 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.69 | 2.43 % | $ 28.9 M | USA |